期刊文献+

替莫唑胺多晶型胶囊的溶出度及其在家兔体内的生物利用度研究 被引量:5

Dissolutions and bioavailabilities of temozolomide capsules with different morphous in rabbits
暂未订购
导出
摘要 目的:研究三种不同形态替莫唑胺(TM)胶囊[TM(A)、TM(B)、TM(C)]的溶出度及其在家兔体内的生物利用度。方法:将三种TM分别制成胶囊剂,测定其在0.1 mol/L盐酸中的溶出度。以家兔为实验动物,分别测定三种TM胶囊的绝对生物利用度,评价其生物等效性。结果:TM(C)胶囊溶出最快,TM(A)次之,TM(B)最慢;TM(A)与TM(B)的生物利用度不存在显著性差异(P>0.05),而TM(C)的生物利用度明显低于TM(A)和TM(B)(P<0.01)。结论:TM(A)与TM(B)在家兔体内具有生物等效性,而TM(C)为低效的一种形态。 Objective: To study three morphological temozolomide (TM) capsules' dissolutions and absolute bioavailabilities in rabbits. Methods: The dissolution of differently morphological TM capsules was determined by UV spectrophotometry. The pharmacokinetics and bioavailability of three morphologies (A, B and C) in rabbits were studied. Results: The results from Weibull's analysis showed that the dissolutions of TM capsules were very different, the dissolution rate of TM(C) was the fastest and that of TM(B) was the slowest; The bioavailability of TM(A) and TM(B) were bioequivalent (P〉0.05), but that of TM(C) was obvious lower than the others (P 〈0.01). Conclusion: TM capsule A and B are bioequivalent and TM(C) is lower in the bioavailability in rabbits.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第9期942-945,共4页 Journal of Shandong University:Health Sciences
关键词 替莫唑胺 多晶型 胶囊 生物利用度 Temozolomide Polymorphism Capsule Bioavailability
  • 相关文献

参考文献4

二级参考文献6

  • 1[1]Newlands ES,Blackledge GRP,Slack JA,et al.Phasel trial of temozolomide[J].Br J Cancer,1992,65:287.
  • 2[2]Baker SD,Wirthm,Statkevich P,et al.Absorption, metabolism,and excretion of 14C-temozolomide following oral adimministration to patients with advanced cancer[J].Clin Cancer Res,1999,5(2):309.
  • 3[3]Newlands ES,Stevens MFG,Wedge SR,et al.Temozolomide:a review of its discovery,chemical properties,pre-clinical development and clinical trials[J].Cancer Treat Rev,1997,23:35.
  • 4[1]Lunt E, Stevens MFG, Stone R, et al. Tetrazine derivative[P]. GB:2104522,1983-03-09. (CA 1983,98:198285)
  • 5[2]Temozolomide[M].Merck Index, 12th,9289:1562.
  • 6[3]Lowe PR, Sansom CE, Schwalbe CH, et al. Antitumor imidazotetrazines. 25. Crystal structure of 8 carbamoyl-3-methylimidazo [5, 1-d ]-1, 2, 3, 5-tetrazin-4 (3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTIC[J]. J Med Chem, 1992,35(18) :3377-3382.

共引文献41

同被引文献84

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部